Germacranolides from Enhydra fluctuans with TRAIL-resistance Abrogating Activity

TRAIL selectively kills cancer cells without harming most normal cells. However, TRAIL resistance is a major problem for its therapeutic use. Developing a strategy to overcome resistance is crucial...